---
title: 'Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations:
  A case report'
date: '2024-04-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38635290/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240418180524&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Individual sirolimus whole blood concentrations are highly variable,
  critically influenced by the concomitant use of cytochrome P450 (CYP) 3A inducers
  or inhibitors, and also modulated by food. Therapeutic drug monitoring is therefore
  recommended, especially at treatment start or in circumstances that can influence
  sirolimus exposure. In this case report, we highlight the challenge of achieving
  therapeutic sirolimus concentrations and present pragmatic solutions with regimen
  ...
disable_comments: true
---
Individual sirolimus whole blood concentrations are highly variable, critically influenced by the concomitant use of cytochrome P450 (CYP) 3A inducers or inhibitors, and also modulated by food. Therapeutic drug monitoring is therefore recommended, especially at treatment start or in circumstances that can influence sirolimus exposure. In this case report, we highlight the challenge of achieving therapeutic sirolimus concentrations and present pragmatic solutions with regimen ...